A novel deconvolution method for modeling UDP-N-acetyl-D-glucosamine biosynthetic pathways based on 13C mass isotopologue profiles under non-steady-state conditions

BackgroundStable isotope tracing is a powerful technique for following the fate of individual atoms through metabolic pathways. Measuring isotopic enrichment in metabolites provides quantitative insights into the biosynthetic network and enables flux analysis as a function of external perturbations. NMR and mass spectrometry are the techniques of choice for global profiling of stable isotope labeling patterns in cellular metabolites. However, meaningful biochemical interpretation of the labeling data requires both quantitative analysis and complex modeling. Here, we demonstrate a novel approach that involved acquiring and modeling the timecourses of 13C isotopologue data for UDP-N-acetyl-D-glucosamine (UDP-GlcNAc) synthesized from [U-13C]-glucose in human prostate cancer LnCaP-LN3 cells. UDP-GlcNAc is an activated building block for protein glycosylation, which is an important regulatory mechanism in the development of many prominent human diseases including cancer and diabetes.ResultsWe utilized a stable isotope resolved metabolomics (SIRM) approach to determine the timecourse of 13C incorporation from [U-13C]-glucose into UDP-GlcNAc in LnCaP-LN3 cells. 13C Positional isotopomers and isotopologues of UDP-GlcNAc were determined by high resolution NMR and Fourier transform-ion cyclotron resonance-mass spectrometry. A novel simulated annealing/genetic algorithm, called 'Genetic Algorithm for Isotopologues in Metabolic Systems' (GAIMS) was developed to find the optimal solutions to a set of simultaneous equations that represent the isotopologue compositions, which is a mixture of isotopomer species. The best model was selected based on information theory. The output comprises the timecourse of the individual labeled species, which was deconvoluted into labeled metabolic units, namely glucose, ribose, acetyl and uracil. The performance of the algorithm was demonstrated by validating the computed fractional 13C enrichment in these subunits against experimental data. The reproducibility and robustness of the deconvolution were verified by replicate experiments, extensive statistical analyses, and cross-validation against NMR data.ConclusionsThis computational approach revealed the relative fluxes through the different biosynthetic pathways of UDP-GlcNAc, which comprises simultaneous sequential and parallel reactions, providing new insight into the regulation of UDP-GlcNAc levels and O-linked protein glycosylation. This is the first such analysis of UDP-GlcNAc dynamics, and the approach is generally applicable to other complex metabolites comprising distinct metabolic subunits, where sufficient numbers of isotopologues can be unambiguously resolved and accurately measured.

[1]  W. Mckeehan,et al.  Glycolysis, glutaminolysis and cell proliferation. , 1982, Cell biology international reports.

[2]  Marta Cascante,et al.  Dynamic profiling of the glucose metabolic network in fasted rat hepatocytes using [1,2-13C2]glucose. , 2004, The Biochemical journal.

[3]  Vitaly A. Selivanov,et al.  Software for dynamic analysis of tracer-based metabolomic data: estimation of metabolic fluxes and their statistical analysis , 2006, Bioinform..

[4]  Richard M Higashi,et al.  Prospects for clinical cancer metabolomics using stable isotope tracers. , 2009, Experimental and molecular pathology.

[5]  Vitaly A. Selivanov,et al.  An optimized algorithm for flux estimation from isotopomer distribution in glucose metabolites , 2004, Bioinform..

[6]  U. Sauer,et al.  Article number: 62 REVIEW Metabolic networks in motion: 13 C-based flux analysis , 2022 .

[7]  Suzanne Wehrli,et al.  Artificial tumor model suitable for monitoring 31P and 13C NMR spectroscopic changes during chemotherapy‐induced apoptosis in human glioma cells , 2005, Magnetic resonance in medicine.

[8]  Hunter N. B. Moseley,et al.  Correcting for the effects of natural abundance in stable isotope resolved metabolomics experiments involving ultra-high resolution mass spectrometry , 2010, BMC Bioinformatics.

[9]  Andrew N. Lane,et al.  Metabolomics-edited transcriptomics analysis of Se anticancer action in human lung cancer cells , 2006, Metabolomics.

[10]  H. Blanch,et al.  Examination of primary metabolic pathways in a murine hybridoma with carbon‐13 nuclear magnetic resonance spectroscopy , 1994, Biotechnology and bioengineering.

[11]  J. Dennis,et al.  Genome‐scale identification of UDP‐GlcNAc‐dependent pathways , 2008, Proteomics.

[12]  H. Akaike A new look at the statistical model identification , 1974 .

[13]  Richard M Higashi,et al.  Stable isotope‐assisted metabolomics in cancer research , 2008, IUBMB life.

[14]  Andrew N Lane,et al.  NMR-based stable isotope resolved metabolomics in systems biochemistry , 2011, Journal of biomolecular NMR.

[15]  A. Lane,et al.  Stable isotope-resolved metabolomics (SIRM) in cancer research with clinical application to nonsmall cell lung cancer. , 2011, Omics : a journal of integrative biology.

[16]  T. Fan,et al.  Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM) , 2009, Molecular Cancer.

[17]  G. Hart,et al.  The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways , 2010, Journal of Cell Science.

[18]  Jürg Müller,et al.  Essential Role of the Glycosyltransferase Sxc/Ogt in Polycomb Repression , 2009, Science.

[19]  J. Hanover,et al.  The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. , 2010, Biochimica et biophysica acta.

[20]  R. Deberardinis,et al.  Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.

[21]  Kenneth J. Kauffman,et al.  Advances in flux balance analysis. , 2003, Current opinion in biotechnology.

[22]  A. W. Schüttelkopf,et al.  Structural insights into mechanism and specificity of O-GlcNAc transferase , 2008, The EMBO journal.

[23]  Andrew N Lane,et al.  The promise of metabolomics in cancer molecular therapeutics. , 2004, Current opinion in molecular therapeutics.

[24]  Andrew N. Lane,et al.  Structure-based profiling of metabolites and isotopomers by NMR , 2008 .

[25]  Yi E. Sun,et al.  Quantitation of O-Glycosylation Stoichiometry and Dynamics using Resolvable Mass Tags , 2010, Nature chemical biology.

[26]  B O Palsson,et al.  Optimal selection of metabolic fluxes for in vivo measurement. I. Development of mathematical methods. , 1992, Journal of theoretical biology.

[27]  Andrew N. Lane,et al.  Quantification and identification of isotopomer distributions of metabolites in crude cell extracts using 1H TOCSY , 2007, Metabolomics.

[28]  G. Hart,et al.  O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. , 2004, Biochimica et biophysica acta.

[29]  Jan Schellenberger,et al.  Use of Randomized Sampling for Analysis of Metabolic Networks* , 2009, Journal of Biological Chemistry.

[30]  D. Fell,et al.  Fat synthesis in adipose tissue. An examination of stoichiometric constraints. , 1986, The Biochemical journal.

[31]  N. Isern,et al.  c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry , 2009, Oncogene.

[32]  D. McClain,et al.  Up-regulation of O-GlcNAc Transferase with Glucose Deprivation in HepG2 Cells Is Mediated by Decreased Hexosamine Pathway Flux* , 2009, Journal of Biological Chemistry.

[33]  T. Jenuwein,et al.  Role of the polycomb repressive complex 2 in acute promyelocytic leukemia. , 2007, Cancer cell.

[34]  Andrew N Lane,et al.  A novel deconvolution method for modeling UDP-N-acetyl-D-glucosamine biosynthetic pathways based on 13C mass isotopologue profiles under non-steady-state conditions , 2012, BMC Biology.

[35]  S. Lloyd,et al.  A critical perspective of the use of (13)C-isotopomer analysis by GCMS and NMR as applied to cardiac metabolism. , 2004, Metabolic engineering.

[36]  Andrew N Lane,et al.  Isotopomer-based metabolomic analysis by NMR and mass spectrometry. , 2008, Methods in cell biology.

[37]  Feng Han,et al.  GlcNAcylation plays an essential role in breast cancer metastasis. , 2010, Cancer research.